Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Low Vitamin D Persists Year-Round in Northern Britain
Screening data from a UK clinical trial found low vitamin D levels in 55% of older patients and 72% of ethnic patients, with little variation despite summer months.
Clinical Report: Low Vitamin D Persists Year-Round in Northern Britain
Overview
A study found that over half of older patients and nearly three-quarters of ethnic patients in northern Britain had vitamin D insufficiency or deficiency, with little seasonal variation.
Background
Vitamin D insufficiency is a significant public health concern, particularly among older adults and ethnic minorities who may have limited sun exposure. Understanding the prevalence of vitamin D deficiency is crucial.
Data Highlights
Group
Prevalence of Insufficiency/Deficiency
Mean Serum 25(OH)D Level (nmol/L)
Older Patients (≥65 years)
55%
50
Ethnic Patients (≥18 years)
72%
40
Key Findings
55% of older patients had serum 25-hydroxyvitamin D levels below 50 nmol/L.
72% of ethnic patients had serum 25-hydroxyvitamin D levels below 50 nmol/L.
Vitamin D insufficiency or deficiency persisted across all seasons, with no significant decline during summer months.
Among older patients, the prevalence of insufficiency during June through August was 56%.
Ethnic patients maintained high rates of insufficiency throughout winter, spring, and summer.
Clinical Implications
Clinicians should be aware that vitamin D status may not improve in summer for high-risk groups, such as older adults and ethnic minorities. Regular screening and appropriate supplementation strategies may be necessary to address persistent vitamin D insufficiency in these populations.
Conclusion
The study reports high rates of vitamin D insufficiency among high-risk groups in northern Britain.
The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
